Risedronate Sodium 63304-0440-09
- Manufacturer
- Sun Pharmaceutical Industires Inc.
- Dosage Form
- Tablet, Delayed Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 10, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA203925
Need to source Risedronate Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risedronate Sodium | 35 mg/1 |
Drug Class
Bisphosphonate [EPC]Diphosphonates [CS]
Selected Package
63304-0440-09Selected1 DOSE PACK in 1 CARTON (63304-440-09) / 4 TABLET, DELAYED RELEASE in 1 DOSE PACK (63304-440-11)